These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30723616)

  • 1. GRID-independent molecular descriptor analysis and molecular docking studies to mimic the binding hypothesis of γ-aminobutyric acid transporter 1 (GAT1) inhibitors.
    Zafar S; Jabeen I
    PeerJ; 2019; 7():e6283. PubMed ID: 30723616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Dynamic Simulations to Probe Stereoselectivity of Tiagabine Binding with Human GAT1.
    Zafar S; Jabeen I
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of selected antiepileptics used in neuropathic pain as human GABA transporter isoform 1 (GAT1) inhibitors-Molecular docking and pharmacodynamic studies.
    Fijałkowski Ł; Sałat K; Podkowa A; Zaręba P; Nowaczyk A
    Eur J Pharm Sci; 2017 Jan; 96():362-372. PubMed ID: 27721044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the Activity of Selected Highly Lipophilic Compounds toward hGAT1 Inhibition. Part II.
    Nowaczyk A; Fijałkowski Ł; Kowalska M; Podkowa A; Sałat K
    ACS Chem Neurosci; 2019 Jan; 10(1):337-347. PubMed ID: 30222312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, Function, and Modulation of γ-Aminobutyric Acid Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic Prospective.
    Zafar S; Jabeen I
    Front Chem; 2018; 6():397. PubMed ID: 30255012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1).
    Jurik A; Zdrazil B; Holy M; Stockner T; Sitte HH; Ecker GF
    J Med Chem; 2015 Mar; 58(5):2149-58. PubMed ID: 25679268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for substrate recognition and transport of human GABA transporter GAT1.
    Zhu A; Huang J; Kong F; Tan J; Lei J; Yuan Y; Yan C
    Nat Struct Mol Biol; 2023 Jul; 30(7):1012-1022. PubMed ID: 37400655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and Simulation of
    Zafar S; Nguyen ME; Muthyala R; Jabeen I; Sham YY
    Comput Struct Biotechnol J; 2019; 17():61-69. PubMed ID: 30619541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA transporters as drug targets for modulation of GABAergic activity.
    Schousboe A; Sarup A; Larsson OM; White HS
    Biochem Pharmacol; 2004 Oct; 68(8):1557-63. PubMed ID: 15451399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking and pharmacodynamic studies on hGAT1 inhibition activity in the presence of selected neuronal and astrocytic inhibitors. Part I.
    Nowaczyk A; Fijałkowski Ł; Zaręba P; Sałat K
    J Mol Graph Model; 2018 Oct; 85():171-181. PubMed ID: 30219588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of GABA reuptake inhibition.
    Motiwala Z; Aduri NG; Shaye H; Han GW; Lam JH; Katritch V; Cherezov V; Gati C
    Nature; 2022 Jun; 606(7915):820-826. PubMed ID: 35676483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of sialic acid in the regulation of γ--aminobutyric acid uptake activity of γ-aminobutyric acid transporter 1.
    Hu J; Fei J; Reutter W; Fan H
    Glycobiology; 2011 Mar; 21(3):329-39. PubMed ID: 21045010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.
    Eckstein-Ludwig U; Fei J; Schwarz W
    Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-dependent GABA-induced currents in GAT1-transfected HeLa cells.
    Risso S; DeFelice LJ; Blakely RD
    J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):691-702. PubMed ID: 8683468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion binding and permeation at the GABA transporter GAT1.
    Mager S; Kleinberger-Doron N; Keshet GI; Davidson N; Kanner BI; Lester HA
    J Neurosci; 1996 Sep; 16(17):5405-14. PubMed ID: 8757253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2.
    White HS; Watson WP; Hansen SL; Slough S; Perregaard J; Sarup A; Bolvig T; Petersen G; Larsson OM; Clausen RP; Frølund B; Falch E; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2005 Feb; 312(2):866-74. PubMed ID: 15550575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents.
    Lutz T; Wein T; Höfner G; Wanner KT
    ChemMedChem; 2017 Mar; 12(5):362-371. PubMed ID: 28125164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of the gamma-aminobutyric acid transporter 1 (GAT1) do not reveal a channel mode of conduction.
    Matthews E; Rahnama-Vaghef A; Eskandari S
    Neurochem Int; 2009 Dec; 55(8):732-40. PubMed ID: 19622377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAT1 (GABA:Na+:Cl-) cotransport function. Steady state studies in giant Xenopus oocyte membrane patches.
    Lu CC; Hilgemann DW
    J Gen Physiol; 1999 Sep; 114(3):429-44. PubMed ID: 10469733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative review on the well-studied GAT1 and the understudied BGT-1 in the brain.
    Bhatt M; Gauthier-Manuel L; Lazzarin E; Zerlotti R; Ziegler C; Bazzone A; Stockner T; Bossi E
    Front Physiol; 2023; 14():1145973. PubMed ID: 37123280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.